Overview

Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD

Status:
NOT_YET_RECRUITING

Trial end date:
2026-03-01

Target enrollment:

Participant gender:

Summary

This study will examine the safety and preliminary efficacy of psilocybin mushrooms to treat adults with PTSD. Up to 24 participants will take part in this study. Each participant will ingest psilocybin from dried mushrooms in a chocolate formulation.

Phase:

PHASE1

Details

Lead Sponsor:

Sue Sisley

Collaborator:

Scottsdale Research Institute

Treatments:

Hallucinogens